XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0.99%5.69B | 8.96%1.36B | -3.09%1.54B | -0.12%1.67B | -0.44%1.13B | -18.41%5.64B | -5.52%1.25B | -12.39%1.58B | -21.99%1.67B | -30.83%1.13B |
Operating revenue | 1.26%5.56B | 9.46%1.33B | -3.30%1.5B | 0.49%1.64B | -0.27%1.1B | -18.64%5.49B | -5.37%1.22B | -12.70%1.55B | -22.44%1.63B | -30.97%1.1B |
Cost of revenue | 1.47%3.72B | 9.11%886M | -3.76%998M | 1.47%1.11B | 0.41%726M | -17.01%3.66B | -5.03%812M | -11.37%1.04B | -22.11%1.09B | -26.82%723M |
Gross profit | 0.10%1.97B | 8.68%476M | -1.83%537M | -3.11%561M | -1.96%400M | -20.90%1.97B | -6.41%438M | -14.26%547M | -21.76%579M | -36.94%408M |
Operating expense | -3.54%1.91B | -0.43%468M | 0.61%497M | -6.89%473M | -7.09%472M | -11.25%1.98B | -5.62%470M | -5.73%494M | -13.90%508M | -17.93%508M |
Selling and administrative expenses | -7.85%587M | -2.76%141M | 1.25%162M | -12.50%140M | -16.28%144M | -0.47%637M | -2.03%145M | 5.96%160M | -10.61%160M | 6.17%172M |
-Selling and marketing expense | -9.30%195M | -3.70%52M | -8.93%51M | -16.07%47M | -8.16%45M | -14.68%215M | -5.26%54M | -5.08%56M | -22.22%56M | -23.44%49M |
-General and administrative expense | -7.11%392M | -2.20%89M | 6.73%111M | -10.58%93M | -19.51%99M | 8.76%422M | 0.00%91M | 13.04%104M | -2.80%104M | 25.51%123M |
Depreciation amortization depletion | 1.02%198M | 0.00%47M | -4.00%48M | -2.04%48M | 10.00%55M | -8.41%196M | -14.55%47M | -5.66%50M | -10.91%49M | -1.96%50M |
-Depreciation and amortization | 1.02%198M | 0.00%47M | -4.00%48M | -2.04%48M | 10.00%55M | -8.41%196M | -14.55%47M | -5.66%50M | -10.91%49M | -1.96%50M |
Other operating expenses | -1.92%1.13B | 0.72%280M | 1.06%287M | -4.68%285M | -4.55%273M | -16.70%1.15B | -5.76%278M | -11.25%284M | -16.01%299M | -29.56%286M |
Operating profit | 900.00%64M | 125.00%8M | -24.53%40M | 23.94%88M | 28.00%-72M | -103.05%-8M | -6.67%-32M | -53.51%53M | -52.67%71M | -457.14%-100M |
Net non-operating interest income expense | -1.32%-153M | 2.70%-36M | -2.70%-38M | -2.56%-40M | -2.63%-39M | -33.63%-151M | 0.00%-37M | -23.33%-37M | -39.29%-39M | -111.11%-38M |
Non-operating interest expense | 1.32%153M | -2.70%36M | 2.70%38M | 2.56%40M | 2.63%39M | 33.63%151M | 0.00%37M | 23.33%37M | 39.29%39M | 111.11%38M |
Other net income (expense) | -227.03%-47M | 66.67%-21M | -99.35%1M | 0.00%-10M | 61.36%-17M | 107.84%37M | 87.22%-63M | 955.56%154M | -350.00%-10M | -225.71%-44M |
Special income (charges) | -181.82%-45M | 69.84%-19M | --0 | 10.00%-9M | 41.38%-17M | 109.00%55M | 87.22%-63M | 926.32%157M | -233.33%-10M | 69.79%-29M |
-Less:Restructuring and merger&acquisition | -34.69%32M | -11.11%8M | -33.33%6M | 16.67%7M | -56.00%11M | 53.13%49M | 0.00%9M | -43.75%9M | 100.00%6M | 525.00%25M |
-Less:Impairment of capital assets | -69.23%20M | -79.63%11M | -66.67%1M | -50.00%2M | 50.00%6M | -86.54%65M | -88.75%54M | 0.00%3M | --4M | --4M |
-Less:Other special charges | 95.86%-7M | ---- | 95.86%-7M | ---- | ---- | -276.04%-169M | --0 | ---169M | ---- | ---- |
Other non- operating income (expenses) | 88.89%-2M | ---2M | 133.33%1M | ---1M | ---- | -112.95%-18M | --0 | -400.00%-3M | ---- | -111.45%-15M |
Income before tax | -11.48%-136M | 62.88%-49M | -98.24%3M | 72.73%38M | 29.67%-128M | 62.23%-122M | 76.43%-132M | 157.58%170M | -82.54%22M | -504.44%-182M |
Income tax | 86.67%-2M | 159.09%13M | -95.56%2M | 37.50%11M | 39.13%-28M | 77.94%-15M | 81.67%-22M | 462.50%45M | -75.00%8M | -483.33%-46M |
Earnings from equity interest net of tax | -22.22%7M | -150.00%-1M | 50.00%6M | -40.00%3M | 50.00%-1M | 132.14%9M | 116.67%2M | 300.00%4M | 225.00%5M | 80.00%-2M |
Net income | -29.59%-127M | 41.67%-63M | -94.57%7M | 57.89%30M | 26.81%-101M | 65.37%-98M | 76.11%-108M | 130.36%129M | -78.89%19M | -700.00%-138M |
Net income continuous Operations | -29.59%-127M | 41.67%-63M | -94.57%7M | 57.89%30M | 26.81%-101M | 65.37%-98M | 76.11%-108M | 130.36%129M | -78.89%19M | -700.00%-138M |
Minority interest income | 200.00%1M | 200.00%1M | 0 | 0 | 0 | -125.00%-1M | -200.00%-1M | 0 | 0 | 0 |
Net income attributable to the parent company | -31.96%-128M | 40.19%-64M | -94.57%7M | 57.89%30M | 26.81%-101M | 66.20%-97M | 76.38%-107M | 134.55%129M | -78.41%19M | -700.00%-138M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -31.96%-128M | 40.19%-64M | -94.57%7M | 57.89%30M | 26.81%-101M | 66.20%-97M | 76.38%-107M | 134.55%129M | -78.41%19M | -700.00%-138M |
Basic earnings per share | -30.68%-1.15 | 40.21%-0.58 | -94.87%0.06 | 58.82%0.27 | 27.78%-0.91 | 65.08%-0.88 | 76.57%-0.97 | 138.78%1.17 | -77.63%0.17 | -730.00%-1.26 |
Diluted earnings per share | -30.68%-1.15 | 40.21%-0.58 | -94.78%0.06 | 58.82%0.27 | 27.78%-0.91 | 65.08%-0.88 | 76.57%-0.97 | 139.58%1.15 | -77.33%0.17 | -763.16%-1.26 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |